Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-22T15:38:55.646Z Has data issue: false hasContentIssue false

Analysis of Japanese encephalitis epidemic in western Nepal in 1997

Published online by Cambridge University Press:  09 April 2001

T. AKIBA
Affiliation:
Japan International Cooperation Agency (JICA) Project Office, Human Resource Development Division/Ministry of Health, Accra, Ghana
K. OSAKA
Affiliation:
Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan
S. TANG
Affiliation:
Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK
M. NAKAYAMA
Affiliation:
Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan
A. YAMAMOTO
Affiliation:
Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan
I. KURANE
Affiliation:
Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan
N. OKABE
Affiliation:
Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan
T. UMENAI
Affiliation:
Department of Health Policy and Planning, The University of Tokyo
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We conducted an epidemiological study of a Japanese encephalitis (JE) outbreak in the southwestern part of Nepal in 1997. A high density of JE infections was found and it was estimated that 27·9% the total population were infected with JE virus in the study area. The fatality rate was 13·2% and there was no difference in the fatality rate between males and females over 5 years old. However, the case fatality rate was 2·1 times higher in females than in males (14·6% vs. 6·9%) among children under 5 years of age. Fifty-three blood samples were collected from suspected JE cases during the epidemic period in 1998. Findings for JE specific IgM revealed that clinical diagnoses of JE were serologically confirmed in an average 78% (70–93%) of patients in three collaborating hospitals. These studies demonstrated that JE was highly prevalent in the area and clinical diagnoses were reliable. Effective preventive measures should be taken against this vaccine-preventable disease.

Type
Research Article
Copyright
© 2001 Cambridge University Press